Xiangyun Kong

MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2

Wei Jiang, Huiyun Yang, Guanjie Qin, 2022, Cell Death & Disease.

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study

Wei Jiang, Jinglin Mi, Shufang Liao, 2019, Cancer Chemotherapy and Pharmacology.

Candidate tumor suppressor ZNF154 suppresses invasion and metastasis in NPC by inhibiting the EMT via Wnt/β-catenin signalling

Wei Jiang, Qiuqiu Chen, Hua-ying Tang, 2017, Oncotarget.

Methylation‐associated silencing of miR‐9‐1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2

Wei Jiang, Hua-ying Tang, Guanjie Qin, 2021, Cancer science.

Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study

Wei Jiang, Qiuqiu Chen, Bin Zhang, 2016, Oncotarget.

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Wei Jiang, Bin Zhang, Yunyan Mo, 2020, Oral oncology.

Hypofractionated Radiotherapy compared with Conventionally Fractionated Radiotherapy to treat Initial Distant Metastases in Nasopharyngeal Carcinoma: A Multicenter, prospective, randomized, Phase II Trial.

Wei Jiang, Bin Zhang, Yunyan Mo, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.

Yunyan Mo, Yuan Xie, Yixin Su, 2024, JAMA oncology.

An individualized immune prognostic signature in nasopharyngeal carcinoma.

Yunyan Mo, Shufang Liao, Yuan Xie, 2024, Oral oncology.